Michael Taranto

Michael Taranto is an accomplished professional in the field of research and development procurement with extensive experience across leading biotech and pharmaceutical companies. Currently serving as Director of R&D and Clinical Procurement at Iovance Biotherapeutics, Inc. since August 2022, Michael previously held the role of Associate Director, R&D Strategic Sourcing and Procurement at Bristol Myers Squibb, managing CRO Services and the Cell Therapy Development Portfolio. Michael's expertise is further highlighted by significant contributions as Global Lead for the BB2121 (ide-cel) Development Program during the tenure at Celgene, where roles included Associate Director and Senior Manager. Additional experience includes managerial positions in clinical outsourcing and project coordination at TFS Trial Form Support and BioClinica, respectively. Michael holds a Master of Business Administration from Montclair State University and a Bachelor of Science in Biology and Chemistry from The College of New Jersey.